Long Corridor Asset Management LTD Monte Rosa Therapeutics, Inc. Transaction History
Long Corridor Asset Management LTD
- $80.6 Million
- Q2 2024
A detailed history of Long Corridor Asset Management LTD transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 40,000 shares of GLUE stock, worth $203,600. This represents 0.18% of its overall portfolio holdings.
Number of Shares
40,000
Previous 40,000
-0.0%
Holding current value
$203,600
Previous $282,000
47.16%
% of portfolio
0.18%
Previous 0.41%
Shares
1 transactions
Others Institutions Holding GLUE
# of Institutions
78Shares Held
40.6MCall Options Held
84.2KPut Options Held
20.6K-
Nea Management Company, LLC Timonium, MD7.69MShares$39.2 Million2.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.98MShares$30.4 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$25 Million0.24% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.54MShares$23.1 Million0.23% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.66MShares$13.5 Million0.42% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $238M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...